Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19

Given the speed of viral infection spread, repurposing of existing drugs has been given the highest priority in combating the ongoing COVID-19 pandemic. Only drugs that are already registered or close to registration, and therefore have passed lengthy safety assessments, have a chance to be tested i...

Full description

Bibliographic Details
Main Authors: Ulf Norinder, Astrud Tuck, Kalle Norgren, Vesna Munic Kos
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
COVID-19
Antiviral drugs
Drug repositioning
Lysosomotropism
Endosomal pathway
Broad spectrum antivirals
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220307757

Internet

http://www.sciencedirect.com/science/article/pii/S0753332220307757

Similar Items